Liver stem cells: Prospects for treatment of inherited and acquired liver diseases

Expert Opinion on Biological Therapy

Volumn 3, Issue 3, 2003, Pages 403-408

  Theise, Neil D ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Bioartificial liver devices; Cell transplantation; Gene therapy; Hepatocytes; Liver; Progenitor cells; Stem cells

Indexed keywords

BIOARTIFICIAL ORGAN; CELL COMPARTMENTALIZATION; CELL DAMAGE; CELL POPULATION; CELL TRANSPLANTATION; CLINICAL TRIAL; GENE THERAPY; GENETIC DISORDER; HUMAN; LIVER CELL; LIVER DISEASE; LIVER REGENERATION; MESENCHYME; REVIEW; STEM CELL;

ANIMALS; HEPATOCYTES; HUMANS; LIVER DISEASES; STEM CELLS;

VERTEBRATA;

EID: 0037526657     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.3.3.403     Document Type: Review

References (73)

1. PETERSEN BE, BOWEN WC, PATRENE KD et al.: Bone marrow as a potential source of hepatic oval cells. Science (1999) 284:1168-1170. The first report of hepatocyte and oval cell derivation from bone marrow, in marked liver injury, in rodents.
2. THEISE ND, BADVE S, SAXENA R et al.: Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology (2000) 31:235-240. First confirmatory report of Petersen's earlier finding of rodent liver from bone marrow, but in the absence of severe injury.
3. THEISE ND, SAXENA R, PORTMANN BC et al.: The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 30:1425-1433. The first study to definitely show regeneration from an intrahepatic stem/ progenitor cell compartment in human livers.
4. FALKOWSKI O, WEST AB, CHIRIBOGA L et al.: Regeneration of hepatocyte 'buds' in cirrhosis from interbiliary stem cells. J. Hepatol. (2003) (in press).
5. THEISE ND, NIMMAKAYALU M, GARDNER R et al.: Liver from bone marrow in humans. Hepatology (2000) 32:11-16. The first report of hepatic parenchymal cells repopulated by circulating, marrow-derived cells in humans with and without severe injury.
6. ALISON MR, POULSOM R, JEFFERY R et al.: Hepatocytes from non-hepatic adult stem cells. Nature (2000) 406:257.
7. BAUMANN U, CROSBY HA, RAMANI P, KELLY DA, STRAIN AJ: Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell? Hepatology (1999) 30:112-117.
8. SELL S: Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology (2001) 33:738-750.
9. THEISE ND, KRAUSE DS: Bone marrow to liver: the blood of Prometheus. Semin. Cell Dev. Biol. (2002) 13:411-417.
10. OVERTURF K, AL-DHALIMY M, TANGUAY R et al.: Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia Type I. Nat Genet. (1996) 12:266-273. The definitive study demonstrating the 'stem-cell like' potential of mature hepatocytes to self-renew and repopulate damaged liver.
11. WULF GG, LUO K-L, JACKSON KA, BRENNER MK, GOODELL MA: Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica (2003) 88:368-378.
12. LAGASSE E, CONNORS H, AL DHALIMY M et al.: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. (2000) 6:1229-1234.
13. KRAUSE DS, THEISE ND, COLLECTOR MI et al.: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell (2001) 105:369-377. The first study to show clonal origin of mesodermal, ectodermal and endodermal tissues, that is, 'true plasticity', from a single adult hematopoietic stem cell.
14. KORBLING M, KATZ RL, KHANNA A et al.: Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N. Engl. J. Med. (2002) 346:738-746.
15. MALLET VO, MITCHELL C, MEZEY E et al.: Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo. Hepatology (2002) 35:799-804.
16. WANG X, MONTINI E, AL-DHALIMY M, LAGASSE E, FINEGOLD M, GROMPE M: Kinetics of liver repopulation after bone marrow transplantation. Am. J. Pathol. (2002) 161:565-574.
17. KLEEBERGER W, ROTHAMEL T, GLOCKNER S, FLEMMING P, LEHMANN U, KREIPE H: High Frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology (2002) 35:110-116.
18. WANG X, GE S, MCNAMARA G, HAO QL, CROOKS GM, NOLTA JA: Albumin expressing hepatocyte-like cells develop in the livers of immune-defident mice transmitted with highly purified human hematopoietic stem cells. Blood (2003) (epub ahead of print).
19. WAGERS AJ, SHERWOOD RI, CHRISTENSEN JL, WEISSMAN IL: Little evidence for developmental plasticity of adult hematopoietic stem cells. Science (2002) 297:2256-2259.
20. THEISE ND, KRAUSE DS, SHARKIS S: Comments on: 'Little evidence for stem cell plasticity.' Science (2003) 299:1317.
21. WAGERS AJ, SHERWOOD RI, CHRISTENSEN JL, WEISSMAN IL: Response to Comments on: 'Little evidence for stem cell plasticity.' Science (2003) 299:1317.
22. TERADA N, HAMAZAKI T, OKA M et al.: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature (2002) 416:542-545.
23. YING QL, NICHOLS J, EVANS EP, SMITH AG: Changing potency by spontaneous fusion. Nature (2002) 416:545-548.
24. WURMSER AE, GAGE FH: Stem cells: cell fusion causes confusion. Nature (2002) 416:485-487.
25. WANG X, WILLENBRING H, AKKARI Y et al.: Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature (2003) 422:897-901.
26. VASSILOPOULOS G, WANG PR, RUSSELL DW: Transplanted bone marrow regenerates liver by cell fusion. Nature (2003) 422:901-904.
27. IANUS A, HOLZ GG, THEISE ND, HUSSAIN MA: In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. (2003) 111:843-850.
28. DEB A, WANG S, SKELDING KA et al.: Bone marrow-derived cardiomyocytes are present in adult human heart. Circulation (2003) 107:1247-1249.
29. CORTI S, LOCATELLI F, STRAZZER S et al.: Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment. Exp. Neurology (2002) 177:443-452.
30. NEWSOME PN, JOHANNESSEN I, BOYLE S et al.: Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology (2003) (in press).
31. ORLIC D, KAJSTURA J, CHIMENTI S et al.: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA (2001) 98:10344-10349. This study gives the first glimpse of how medical treatments may be the future for diseases currently treated by surgical transplantation or repair procedures. Exogenous G-CSF is used to mobilise marrow-derived progenitors to participate in and improve repair of ischaemically-injured myocardium. This paper can be seen as a model for non-surgical, stem cell-mediated, medical treatment of severe organ injury.
32. PETERSEN BE, HATCH HM, JORGENSEN ML, STOLZ DB: SDF-1 as a potential homing protein for bone marrow derived liver oval cells. FASEB J. (2001) 15:A1084.
33. OHASHI K, PARK F, KAY MA: Hepatocyte transplantation: clincal and experimental application. J. Mol. Med. (2001) 79:617-630.
34. LEE LA: Advances in hepatocyte transplantation: a myth becomes relaity. J. Clin. Invest. (2001) 108:367-369.
35. FOX IJ: Transplantation into and inside the liver. Hepatology (2002) 36:249-251.
36. STROM SC, CHOWDHURY RJ, FOX IJ: Hepatocyte transplantation for the treatment of clinical disease. Semin. Liver Dis. (1999) 19:39-48.
37. STROM S, FISHER R: Hepatocyte transplantation: new possibilities for therapy. Gastroenterology (2003) 124:568-571.
38. WEGE H, LE HT, CHUI MS et al.: Telomerase reconsitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology (2003) 124:432-444.
39. NAGATA H, ITO M, CAI J, EDGE AS, PLATT JL, FOX IJ: Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology (2003) 124:422-431.
40. REYES M, VERFAILLIE CM: Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann. NY Acad. Sci. (2001) 938:231-233.
41. SCHWARTZ RE, REYES M, KOODIE L et al.: Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J. Clin. Invest. (2002) 109:1291-1302.
42. BRILL S, ZVIBEL I, REID LM: Expansion conditions for early hepatic progenitor cells from embryonal and neonatal rat livers. Dig. Dis. Sci. (1999) 44:364-371.
43. YAMADA T, YOSHIKAWA M, KANDA S et al.: In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells (2002) 20:146-154.
44. JONES EA, TOSH D, WILSON DI, LINDSAY S, FORRESTER LM: Hepatic differentiation of murine embryonic stem cells. Exp. Cell Res. (2002) 272:15-22.
45. HAMAZAKI T, IIBOSHI Y, OKA M et al.: Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett. (2001) 497:15-19.
46. CHINZEI R, TANAKA Y, SHIMIZU-SATO K et al.: Embryoid body cells derived from mouse embryonic stem cells show differentiation into functional hepatocytes. Hepatology (2002) 36:22-29.
47. MIYASHITA H, SUZUKI A, FAFAO K, NAKAUCHI H, TANIGUCHI H: Evidence for hepatocyte differentiation from embryonic stem cells in vitro. Cell Transplant (2002) 11:429-434.
48. CHOI D, OH HJ, CHANG UJ et al.: In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant (2002) 11:359-368.
49. STANWORTH SJ, NEWLAND AC: Stem cells: progress in research and edging towards the clinical setting. Clin. Med. (2001) 5:378-382.
50. OHASHI K, PARK F, KAY MA: Hepatocyte transplantation: clinical and experimental application. J. Mol. Med. (2001) 79:617-730.
51. SUSICK R, MOSS N, KUBOTA H et al.: Hepatic progenitors and strategies for liver cell therapies. Ann. NY Acad. Sci. (2001) 944:398-419.
52. GROMPE M: Liver repopulation for the treatment of metabolic diseases. J. Inherit. Metab. Dis. (2001) 24:231-244.
53. LACONI E, LACONI S: Principles of hepatocyte repopulation. Semin. Cell Dev. Biol. (2002) 13:433-438.
54. GUPTA S, CHOWDHURY JR: Therapeutic potential of hepatocyte transplantation. Semin. Cell Dev. Biol. (2002) 13:439-446.
55. FOXI J, CHOWDHURY JR, KAUFMAN SS et al.: Treatment of the Crigler-Najjar syndrome Type 1 with hepatocyte transplantation. N. Engl. J. Med. (1998) 338:1422-1426.
56. ROY-CHOWDHURY JR, STROM SC, CHOWDHURY NR, KAUFMAN S, HORSLEN S, FOX IJ: Hepatocyte transplantation in humans: gene therapy and more. Pediatrics (1998) 102:647-648.
57. MURACA M, GERUNDA G, NERI D et al.: Hepatocyte transplantation as a treatment for glycogen storage disease Type 1a. Lancet (2002) 359:317-318.
58. HABIBULLAH CM, SYED IH, QAMAR A, TAHER-UZ Z: Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation (1994) 27:951-952.
59. STROM SC, FISHER RA, THOMPSON MT et al.: Human hepatocyte transplantation in terminal liver failure. Transplantation (1997) 63:559-569.
60. STROM SC, FISHER RA, RUBINSTEIN WS et al.: Transplantation of human hepatocytes. Transplant. Proc. (1997) 29:2103-2106.
61. SORIANO HE, WOOD RP, KANG DC et al.: Hepatocellular transplantation in children with fulminant hepatic failure. Hepatology (1997) 26:239A.
62. BILIAR BM, GUINETTE D, KARRER F et al.: Hepatocyte transplantation in acute liver failure. Liver Transplant (2000) 6:32-40.
63. FISHER RA, BU D, THOMPSON MT et al.: Defining hepatocellular chimerism in a liver failure patient bridged with hepatocyte infusion. Transplantation (2000) 69:303-307.
64. STRAIN AJ, NEUBERGER JM: A bioartificial liver-state of the art. Science (2002) 295:1005-1009.
65. ALLEN JW, BHATIA SN: Improving the next generation of bioartificial liver devices. Semin. Cell Dev. Biol. (2002) 13:447-454.
66. KJAERGARD LL, JIANPING L, ALS-NIELSEN B, GLUUD C: Artificial and bioartificial support systems for acute and acute-on-chronic liver failure. A systematic review. JAMA (2003) 289:217-222.
67. GERLACH JC, ENCKE J, HOLE O, MULLER C, RYAN CJ, NEUHAUS P: Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation (1994) 58:984-988.
68. ROZGA J, PODESTA L, LEPAGE E et al.: A bioartificial liver to treat severe acute liver failure. Ann. Surg. (1994) 219:538-546.
69. PATZER JF II, MAZARIEGOS GV, LOPEZ R et al.: Novel bioartificial liver support system: preclinical evaluation. Ann. NY Acad. Sci. (1999) 875:340-352.
70. SUSSMAN NL, GISLASON GT, CONLIN CA, KELLY JH: The Hepatix extracorporeal liver assist device: initial clinical experience. Artif. Organs (1994) 18:390-396.
71. NYBERG SL, REMMEL RP, MANN HJ, PESHWA MV, HU WS, CERRA FB: Primary hepatocytes outperform HepG2 cells as the source of biotransformation functions in a bioartifical liver. Ann. Surg. (1994) 202:59-67.
72. FISHER JW: Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (2003) 228:1-14.
73. WANLESS IR, NAKASHIMA E, SHERMAN M: Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Arch. Pathol. Lab. Med. (2000) 124:1599-1607. While still very controversial, this study suggests that cirrhosis is a reversible condition. If borne out by further studies, it raises the possibility that metabolic support of people with 'end stage' liver disease, by cell transplantation or bioartificial liver devices, may lead to regression of cirrhosis and diminish the need for organ transplantation.